Mehpare Özkan

Mehpare Özkan

Auto-generated profile, based on publicly available information

Mehpare Özkan

ISTINYE UNIVERSITY, SCHOOL OF MEDICINE

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Pediatric Neurology
Verified
Journal Article
Closed access
BMBaris Malbora
Baris Malbora
DYDeniz Yuksel
Deniz Yuksel
AAAyse Aksoy
Ayse Aksoy
MOMehpare Ozkan
Mehpare Ozkan

30 April 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EAErhan Aksoy
Erhan Aksoy
ÜÖÜlkü Öztoprak
Ülkü Öztoprak
HÇHalil Çelik
Halil Çelik
FÖFatih Mehmet Akif Özdemi̇r
Fatih Mehmet Akif Özdemi̇r
MÖMehpare Özkan
Mehpare Özkan
DYDeniz Yüksel
Deniz Yüksel
Acute necrotizing encephalopathy is a rare type of acute encephalopathy characterized by multi-focal brain lesions and associated severe neurological findings and various organ dysfunctions may accompany it. Patients with acute necrotizing encephalopathy of childhood diagnosed by pediatric neurology and pediatric intensive care at Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital between 2007 and 2020 were included in this study. Nine patients (six females, three males) with a mean age of 4.05±1.94 years (age range 1-6.5) were included in this study. The interval range between fever and encephalopathy in patients was 1-4 days. Influenza A (3H1N1, one untyped) was detected in four patients, influenza B in three patients, and no cause was found in two patients. Major clinical findings other than febrile encephalopathy in all patients were a hemodynamic shock in seven patients, seizures in six patients, vomiting in five patients, dystonia in three patients, and flaccid paralysis in the upper extremity in one patient. Despite all our treatment approaches, including plasmapheresis, moderate to severe neurological sequelae was observed in all of our patients, who survived even with significant radiological improvement. Three patients for whom we could not perform plasmapheresis died. Our study revealed that thalamic involvement increased as the interval shortened, and brainstem involvement increased in patients over four years of age. The presence of persistent vomiting accompanying encephalopathy during the parainfectious period and plasmapheresis treatment being a treatment option that could prevent mortality were cautionary for our study.

25 May 2021 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
ATAysel Taktak
Aysel Taktak
MÖMehpare Özkan
Mehpare Özkan
PZPelin Zorlu
Pelin Zorlu
Amaç: Bu çalışmanın amacı idiyopatik epilepsi tanılı çocuklarda anti epileptik tedavi kesimi sonrası nöbet tekrarına etki eden risk faktörlerini değerlendirmektir. Gereç ve Yöntem: En az 24 ay anti epileptik tedavi alan, kraniyal manyetik rezonans görüntüleme ve elektroensefalografi sonuçları normal olan hastaların ilaç tedavisi 4-6 aylık süreçte azaltılarak kesilmiştir. Tedavi kesimi sonrası nöbeti tekrarlayan 72 hasta relaps grubunu, nöbeti tekrar etmeyen 82 hasta ise remisyon grubunu oluşturmuştur. Sonuç: Hastaların tanı yaşı ve tedavi başlanması sonrasında nöbet kontrol sürelerinin relaps üzerine etki eden risk faktörleri olduğu görülmüştür. Relaps grubundaki hastaların %95,9’unda nöbet tekrarının ilk 2 yıl içerisinde geliştiği belirlenmiştir. Tartışma: Tedavi başlanmasından sonra nöbet kontrol süresi 3 ay ve üzerinde olan hastalarda ilaç kesim sonrası tekrarlama riski daha yüksektir. Ayrıca epilepsi tanı yaşı 12 ve üzerinde olan hastalarda da tekrarlama riskinin yüksek olduğu görülmüştür. Bununla birlikte anti epileptik tedavisi kesilen tüm hastalarda 2 yıl yakın takip önermekteyiz.

30 December 2025 in Abant Medical Journal
Verified
Journal Article
Closed access
HKHülya Kayılıoğlu
Hülya Kayılıoğlu
DYDeniz Yüksel
Deniz Yüksel
AAAyşe Aksoy
Ayşe Aksoy
MÖMehpare Özkan
Mehpare Özkan
ÜÖÜlkühan Öztoprak
Ülkühan Öztoprak
VDVehbi Doğan
Vehbi Doğan
Objective: Chorea is a rare hyperkinetic movement disorder in children, characterized by involuntary, irregular, and rapid movements. Sydenham’s chorea (SC), an autoimmune complication of rheumatic fever, is the most common cause of chorea in pediatric populations. This study aims to retrospectively evaluate the clinical features, neuroimaging findings, treatment responses, and prognostic factors in children with choreiform movement disorders, with a focus on relapse rates and treatment efficacy.Materials and Methods: We conducted a retrospective review of pediatric patients diagnosed with choreiform movement disorders at Dr. Sami Ulus Children's Hospital between 2010 and 2018. Demographic data, clinical presentation, neuroimaging findings, treatments, and relapse outcomes were analyzed.Results: Of the 74 patients, 94.6% had secondary chorea, with 91.9% diagnosed with SC. The mean age at diagnosis was 133.5 ± 33.9 months, with 71.2% female. Brain magnetic resonance imaging findings were normal in 71.4% of the patients who underwent it. Haloperidol was the most commonly used treatment, with 87.3% of SC patients showing a positive response. Relapse occurred in 11.6% of patients, with no significant differences in symptom duration, treatment duration, or age at diagnosis between those with and without relapse (p > 0.05). The median time to relapse was 21 months.Conclusion: SC is the most common cause of chorea in children, and haloperidol is an effective first-line treatment. However, relapses remain a concern, highlighting the need for long-term follow-up. No significant differences were found in clinical parameters between relapsing and non-relapsing patients. Further research is needed to identify relapse predictors.

1 March 2019 in The Journal of Pediatric Research
Verified
Journal Article
Closed access
GKGülin Karacan Küçükali
Gülin Karacan Küçükali
ŞBŞakire Başer
Şakire Başer
MÖMehpare Özkan
Mehpare Özkan
ŞEŞenay Savaş Erdeve
Şenay Savaş Erdeve
ZAZehra Aycan
Zehra Aycan